ICH Considerations: general principles to address the risk of inadvertent germline integration of gene therapy vectors

Current version

PDF icon ICH Considerations

Reference numberCHMP/ICH/469991/2006
KeywordsGene therapy vectors, non-clinical, clinical, biosafety, oncolytic viruses
DescriptionThis document identifies general principles for investigating and addressing risks for inadvertent germline integration. It provides considerations to minimise this potential risk in humans enrolled in clinical trials. This document applies to gene therapy vectors and could also apply to oncolytic viruses.


How useful was this page?

Add your rating